Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran.

Zahra GoudarziFattaneh DanayiKhosro KeshavarzAhmad Gholami

Published in: Cost effectiveness and resource allocation : C/E (2023)

In Iranian settings, CA can significantly increase the quality of life and patients' survival; therefore, in comparison to the Col drug regimen, CA is a cost-effective strategy.

Keyphrases

klebsiella pneumoniae
gram negative
multidrug resistant
end stage renal disease
pseudomonas aeruginosa
ejection fraction
escherichia coli
newly diagnosed
chronic kidney disease
peritoneal dialysis
drug resistant
prognostic factors
acinetobacter baumannii
protein kinase
clinical evaluation